Nikolas K. Haass

Citat de

	Toate	Din 2020
Referințe bibliografice	8924	3423
h-index	46	34
i10-index	87	78

800

400

200

600

20052006200720082009201020112012201320142015201620172018201920202021202220232024202539 83 106 151 259 297 393 399 492 467 505 473 547 551 615 796 757 664 566 550 88

Acces public

Afișați-le pe toate

64 de articole

5 articole

disponibile

indisponibile

Pe baza cerințelor privind finanțarea

Coautori

Helmut SchaiderThe University of QueenslandAdresă de e-mail confirmată pe uq.edu.au
Nethia Mohana KumaranSenior Lecturer, School of Biological Sciences, Universiti Sains MalaysiaAdresă de e-mail confirmată pe usm.my
DINOOP RAVINDRAN MENONUniversity of Colorado Denver, Anshutz Medical campusAdresă de e-mail confirmată pe cuanschutz.edu
Peter HerseyAdresă de e-mail confirmată pe sydney.edu.au
Clemens KreplerMerck& CoAdresă de e-mail confirmată pe merck.com
Peter GunningUniversity of New South WalesAdresă de e-mail confirmată pe unsw.edu.au
Adam McCluskeyUniversity of NewcastleAdresă de e-mail confirmată pe newcastle.edu.au
Mitchell FanePostdoctoral Fellow, Johns Hopkins School of Public HealthAdresă de e-mail confirmată pe jhu.edu
Shweta TikooMedical University of ViennaAdresă de e-mail confirmată pe meduniwien.ac.at
Galina SchevzovResearch FellowAdresă de e-mail confirmată pe unsw.edu.au
Herbert TreutleinSanoosa Pty. Ltd.Adresă de e-mail confirmată pe sanoosa.com
Richard A ScolyerMelanoma Institute Australia, The University of Sydney, Royal Prince Alfred HospitalAdresă de e-mail confirmată pe sswahs.nsw.gov.au
Katherine L NathansonProfessor of Medicine, Perelman School of Medicine at the University of PennsylvaniaAdresă de e-mail confirmată pe upenn.edu
Soyer HPChair in Dermatology, The University of Queensland, Frazer InstituteAdresă de e-mail confirmată pe uq.edu.au
Xu Dong ZhangProfessor, School of Medicine and Public Health, University of Newcastle, AustraliaAdresă de e-mail confirmată pe newcastle.edu.au
yazi keAdresă de e-mail confirmată pe mq.edu.au
Eric MeggersProfessor of Chemistry, Philipps University Marburg (Germany)Adresă de e-mail confirmată pe chemie.uni-marburg.de
Amadeus GladbachUNSW AustraliaAdresă de e-mail confirmată pe unsw.edu.au
Thomas FathProfessor, Macquarie UniversityAdresă de e-mail confirmată pe mq.edu.au
Stuart GallagherSenior Research Officer, Centenary Institute, Sydney. Melanoma Institute of Australia. University ofAdresă de e-mail confirmată pe sydney.edu.au

Urmăriți

Nikolas K. Haass

Professor for Cutaneous Oncology

Adresă de e-mail confirmată pe uq.edu.au

Cutaneous Oncology


Titlu Sortați după descrierea bibliografică Sortați după an Sortați după titlu	Citat de Citat de	Anul
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity J Tsai, JT Lee, W Wang, J Zhang, H Cho, S Mamo, R Bremer, S Gillette, ... Proceedings of the National Academy of Sciences 105 (8), 3041-3046, 2008	1646	2008
Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases KSM Smalley, NK Haass, PA Brafford, M Lioni, KT Flaherty, M Herlyn Molecular cancer therapeutics 5 (5), 1136-1144, 2006	528	2006
Adhesion, migration and communication in melanocytes and melanoma NK Haass, KSM Smalley, L Li, M Herlyn Pigment cell research 18 (3), 150-159, 2005	524	2005
Normal human melanocyte homeostasis as a paradigm for understanding melanoma NK Haass, M Herlyn Journal of Investigative Dermatology Symposium Proceedings 10 (2), 153-163, 2005	295	2005
An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells KSM Smalley, R Contractor, NK Haass, AN Kulp, GE Atilla-Gokcumen, ... Cancer research 67 (1), 209-217, 2007	280	2007
The mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor AZD6244 (ARRY-142886) induces growth arrest in melanoma cells and tumor regression when … NK Haass, K Sproesser, TK Nguyen, R Contractor, CA Medina, ... Clinical Cancer Research 14 (1), 230-239, 2008	272	2008
Targeting glutamine transport to suppress melanoma cell growth Q Wang, KA Beaumont, NJ Otte, J Font, CG Bailey, M van Geldermalsen, ... International journal of cancer 135 (5), 1060-1071, 2014	255	2014
The role of altered cell–cell communication in melanoma progression NK Haass, KSM Smalley, M Herlyn Journal of molecular histology 35, 309-318, 2004	232	2004
A novel class of anticancer compounds targets the actin cytoskeleton in tumor cells JR Stehn, NK Haass, T Bonello, M Desouza, G Kottyan, H Treutlein, ... Cancer research 73 (16), 5169-5182, 2013	207	2013
PLX4032, a potent inhibitor of the B‐Raf V600E oncogene, selectively inhibits V600E‐positive melanomas JT Lee, L Li, PA Brafford, M Van Den Eijnden, MB Halloran, K Sproesser, ... Pigment cell & melanoma research 23 (6), 820-827, 2010	202	2010
Up-regulated expression of zonula occludens protein-1 in human melanoma associates with N-cadherin and contributes to invasion and adhesion KSM Smalley, P Brafford, NK Haass, JM Brandner, E Brown, M Herlyn The American journal of pathology 166 (5), 1541-1554, 2005	192	2005
BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival EF Lee, TJ Harris, S Tran, M Evangelista, S Arulananda, T John, ... Cell death & disease 10 (5), 342, 2019	181	2019
Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up study FJ Moloney, P Guitera, E Coates, NK Haass, K Ho, R Khoury, ... JAMA dermatology 150 (8), 819-827, 2014	160	2014
Microenvironment-driven dynamic heterogeneity and phenotypic plasticity as a mechanism of melanoma therapy resistance F Ahmed, NK Haass Frontiers in oncology 8, 173, 2018	154	2018
In vitro three-dimensional tumor microenvironment models for anticancer drug discovery KSM Smalley, M Lioni, K Noma, NK Haass, M Herlyn Expert opinion on drug discovery 3 (1), 1-10, 2008	149	2008
A stress-induced early innate response causes multidrug tolerance in melanoma D Ravindran Menon, S Das, C Krepler, A Vultur, B Rinner, S Schauer, ... Oncogene 34 (34), 4448-4459, 2015	144	2015
Real‐time cell cycle imaging during melanoma growth, invasion, and drug response NK Haass, KA Beaumont, DS Hill, A Anfosso, P Mrass, MA Munoz, ... Pigment cell & melanoma research 27 (5), 764-776, 2014	143	2014
Modeling Melanoma In Vitro and In Vivo KA Beaumont, N Mohana-Kumaran, NK Haass Healthcare 2 (1), 27-46, 2013	136	2013
Modulation of NOXA and MCL-1 as a strategy for sensitizing melanoma cells to the BH3-mimetic ABT-737 KM Lucas, N Mohana-Kumaran, D Lau, XD Zhang, P Hersey, DC Huang, ... Clinical cancer research 18 (3), 783-795, 2012	126	2012
Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels KSM Smalley, R Contractor, NK Haass, JT Lee, KL Nathanson, ... British journal of cancer 96 (3), 445-449, 2007	107	2007

Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.

Articole 1–20

Referințe bibliografice pe an

Citate duplicat

Citate fuzionate

Adăugați coautoriCoautori

Urmăriți

Citat de

Coautori